These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9142908)
41. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. Ko MT; Huang HC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD J Chin Med Assoc; 2017 Aug; 80(8):467-475. PubMed ID: 28676445 [TBL] [Abstract][Full Text] [Related]
42. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat. Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095 [TBL] [Abstract][Full Text] [Related]
43. Bone morphogenic protein-2 regulates the myogenic differentiation of PMVECs in CBDL rat serum-induced pulmonary microvascular remodeling. Liu C; Chen L; Zeng J; Cui J; Ning JN; Wang GS; Belguise K; Wang X; Qian GS; Lu KZ; Yi B Exp Cell Res; 2015 Aug; 336(1):109-18. PubMed ID: 26071935 [TBL] [Abstract][Full Text] [Related]
44. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats. Abdel Kawy HS Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386 [TBL] [Abstract][Full Text] [Related]
45. Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation. Miyamoto A; Katsuta Y; Zhang XJ; Li HL; Ohsuga M; Komeichi H; Shimizu S; Akimoto T; Mizuno K Hepatol Res; 2010 Jun; 40(6):622-32. PubMed ID: 20412326 [TBL] [Abstract][Full Text] [Related]
47. Left ventricular hypertrophy in rats with biliary cirrhosis. Inserte J; Perelló A; Agulló L; Ruiz-Meana M; Schlüter KD; Escalona N; Graupera M; Bosch J; Garcia-Dorado D Hepatology; 2003 Sep; 38(3):589-98. PubMed ID: 12939585 [TBL] [Abstract][Full Text] [Related]
48. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension. Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142 [TBL] [Abstract][Full Text] [Related]
49. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling. Yi B; Zeng J; Wang G; Qian G; Lu K J Transl Med; 2013 Apr; 11():98. PubMed ID: 23587191 [TBL] [Abstract][Full Text] [Related]
50. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents. Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286 [TBL] [Abstract][Full Text] [Related]
51. [Experimental models for assessment of pulmonary alterations in hepatopulmonary syndrome]. Vercelino R; Tieppo J; Forgiarini Junior LA; Dias AS; Marroni CA; Marroni NP J Bras Pneumol; 2008 Jul; 34(7):453-60. PubMed ID: 18695789 [TBL] [Abstract][Full Text] [Related]
52. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension. Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899 [TBL] [Abstract][Full Text] [Related]
53. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension. Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782 [TBL] [Abstract][Full Text] [Related]
54. Pathophysiology of lung injury induced by common bile duct ligation in mice. Shikata F; Sakaue T; Nakashiro K; Okazaki M; Kurata M; Okamura T; Okura M; Ryugo M; Nakamura Y; Yasugi T; Higashiyama S; Izutani H PLoS One; 2014; 9(4):e94550. PubMed ID: 24733017 [TBL] [Abstract][Full Text] [Related]
56. Activity of brush border membrane enzymes in proximal jejunum of portal hypertensive rats. Kaur U; Kaur S; Mahmood A; Agnihotri N J Gastroenterol; 2001 Jun; 36(6):407-9. PubMed ID: 11428587 [TBL] [Abstract][Full Text] [Related]
57. Hepatoprotective effects of vildagliptin mitigates lung biochemical and histopathological changes in experimental hepatopulmonary syndrome model in rat. Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA Int Immunopharmacol; 2024 Dec; 143(Pt 1):113254. PubMed ID: 39353392 [TBL] [Abstract][Full Text] [Related]
58. Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats. Le Pavec J; Perros F; Eddahibi S; Decante B; Dorfmuller P; Sitbon O; Lebrec D; Humbert M; Mazmanian M; Herve P Eur Respir J; 2009 Sep; 34(3):731-9. PubMed ID: 19324959 [TBL] [Abstract][Full Text] [Related]
59. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats. Heinemann A; Schuligoi R; Lippe IT; Stauber RE Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488 [TBL] [Abstract][Full Text] [Related]
60. Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats. Yokoyama Y; Wawrzyniak A; Sarmadi AM; Baveja R; Gruber HE; Clemens MG; Zhang JX J Gastroenterol Hepatol; 2006 Oct; 21(10):1567-74. PubMed ID: 16928218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]